{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:21:29Z","timestamp":1747200089521,"version":"3.40.5"},"reference-count":30,"publisher":"Media Sphere Publishing House","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["S.S. Korsakov J. Neuro. Psych."],"published-print":{"date-parts":[[2024,4,23]]},"abstract":"<jats:p>Abstracts Objective. To study an influence of the adamantane derivative hemantane on the electrical activity of the brain structures of mice at the early and late (severe) stages of experimental modeling of Parkinson\u2019s disease (PD). Material and methods. For experimental modeling of PD in C57BL\/6J mice, 30 male C57BL\/6J mice weighing 25\u201432 g were systemically (intraperitoneally) administered proneurotoxin MPTP in two modes corresponding to different clinical stages of the disease: 1-methyl-4-phenyl-1.2.3.6-tetrahydropyridine (MPTP) at a dose of 12 mg\/kg, 4 times and 20 mg\/kg, 4 times with an interval of 2 hours, respectively. Results. At the early and late clinical stages of experimental modeling of PD in the brain structures of mice (sensorimotor cortex, substantia nigra, caudate nucleus), EEG desynchronization, an increase in wave amplitude, and an increase in the power spectrum in the range of delta frequencies and beta frequencies are observed at the late symptomatic stage experimental model of PD along with a decrease in electrical activity in the range of 4\u201412 Hz. Preliminary application of the adamantane derivative hemantane at a dose of 20 mg\/kg, both in the early and late clinical stages of PD, prevented an excessive increase in the amplitudes of all groups of waves, normalized theta activity in the range of 4\u201412 Hz, reduced pathological slowing and dysregulation activity in the ranges delta and beta waves, with the prevalence of these effects in the substantia nigra of the brain of animals. Conclusion. The effect of hemantane is more pronounced at the early clinical stage of experimental modeling of PD than at the later (full-scale) stage.<\/jats:p>","DOI":"10.17116\/jnevro2024124091129","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T11:13:52Z","timestamp":1729595632000},"page":"129","source":"Crossref","is-referenced-by-count":0,"title":["Electric activity of the brain at early and late clinical stages of experimental modeling of Parkinson\u2019s disease, an impact of hemantane"],"prefix":"10.17116","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1764-6444","authenticated-orcid":false,"given":"N.A.","family":"Voronina","sequence":"first","affiliation":[{"name":"Institute of General Pathology and Pathophysiology","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4487-0991","authenticated-orcid":false,"given":"I.G.","family":"Kapitsa","sequence":"additional","affiliation":[{"name":"Federal Research Center For Innovator And Emerging Biomedical And Pharmaceutical Technologies","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5071-3581","authenticated-orcid":false,"given":"V.G.","family":"Kucheryanu","sequence":"additional","affiliation":[{"name":"Institute of General Pathology and Pathophysiology","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2540-4303","authenticated-orcid":false,"given":"V.V.","family":"Goloborshchova","sequence":"additional","affiliation":[{"name":"Institute of General Pathology and Pathophysiology","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7065-469X","authenticated-orcid":false,"given":"T.A.","family":"Voronina","sequence":"additional","affiliation":[{"name":"Federal Research Center For Innovator And Emerging Biomedical And Pharmaceutical Technologies","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro2024124091129-1","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-022-00934-6"},{"key":"key-10.17116\/jnevro2024124091129-2","doi-asserted-by":"publisher","DOI":"10.1109\/IEMBS.2009.5334905"},{"key":"key-10.17116\/jnevro2024124091129-3","doi-asserted-by":"publisher","DOI":"10.1023\/a:1006960407008"},{"key":"key-10.17116\/jnevro2024124091129-4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1988.tb03609.x"},{"key":"key-10.17116\/jnevro2024124091129-5","doi-asserted-by":"crossref","unstructured":"Ayele BA, Tesfaye H, Wuhib MZ, et al. Factors Associated with EEG Slowing in Individuals with Parkinson\u2019s Disease. Ethiop J Health Sci. 2022;32(1):73-80","DOI":"10.4314\/ejhs.v32i1.9"},{"key":"key-10.17116\/jnevro2024124091129-6","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm034"},{"key":"key-10.17116\/jnevro2024124091129-7","unstructured":"Nerobkova LN, Voronina TA, Katunina EA, et al. Features of the effects of amantadine on the spatial organization of biopotentials of the brain of patients with parkinsonism. Psikhofarmakologiya i biologicheskayanarkologiya. 2002;2(3):429. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124091129-8","unstructured":"Arakelyan RK, Nerobkova LN, Katunina EA, et al. Features of the functional activity of the brain in patients with Parkinson\u2019s disease during treatment with amantadine sulfate. S.S. Korsakov Journal of Neurology and Psychiatry. 2005;105(4):17-21. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124091129-9","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-191844"},{"key":"key-10.17116\/jnevro2024124091129-10","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00697.2006"},{"key":"key-10.17116\/jnevro2024124091129-11","unstructured":"Nerobkova LN, Val\u2019dman EA, Voronina TA, et al. The effect of a new derivative of aminoadamantan A 7 on the manifestations of parkinsonian syndrome caused by systemic administration of the neurotoxin MPTP Eksperimental\u2019naya i klinicheskayafarmakologiya. 2000;3:3. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124091129-12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2014.04.004"},{"key":"key-10.17116\/jnevro2024124091129-13","doi-asserted-by":"publisher","DOI":"10.25557\/2310-0435.2019.04.57-62"},{"key":"key-10.17116\/jnevro2024124091129-14","unstructured":"Val\u2019dman EA, Voronina TA, Aksenova LN, et al. The effect of the new antiparkinsonian drug Hemantane on monoamine oxidase activity. Eksperimental\u2019naya i klinicheskaya farmakologiya. 2003;66:5:3-5. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124091129-15","unstructured":"Voronina TA, Raevskii KS, Kudrin VS, et al. The effect of a new potential antiparkinsonian agent himantan on the content of monoamines and their metabolites in the rat striatum. Eksperimental\u2019naya i klinicheskaya farmakologiya. 2001;6:13-16. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124091129-16","unstructured":"Ivanova EA, Kapitsa IG, Zolotov NN, et al. Effects of Hemantane upon the level of lipid peroxidation in brain in experimental parkinsonian syndrome. Farmakokinetika I farmakodinamika. [Pharmacokinetics and Pharmacodynamics]. 2016;79(3):9-12. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124091129-17","doi-asserted-by":"publisher","DOI":"10.25557\/2310-0435.2021.02.45-49"},{"key":"key-10.17116\/jnevro2024124091129-18","doi-asserted-by":"publisher","DOI":"10.1134\/S1819712421010165"},{"key":"key-10.17116\/jnevro2024124091129-19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2011.03.007"},{"key":"key-10.17116\/jnevro2024124091129-20","unstructured":"Khaindrava VG, Kozina EA, Kucheryanu VG, et al. Modeling of preclinical and early clinical stages of Parkinson\u2019s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(7):41-47. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124091129-21","unstructured":"Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates. 2nd ed. Publisher, Academic press; 2001;264"},{"key":"key-10.17116\/jnevro2024124091129-22","unstructured":"Mitrofanov AA. Komp\u2019yuternaya sistema analiza i topograficheskogo kartirovaniy aelektricheskoi aktivnosti mozga s neirometricheskim bankom EEG-dannykh \u00abBrainsys\u00bb. M.: Nauchno-meditsinskaya firma \u00abStatokin\u00bb; 2007;72. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124091129-23","doi-asserted-by":"publisher","DOI":"10.1016\/s0306-4522(02)00669-3"},{"key":"key-10.17116\/jnevro2024124091129-24","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.13853"},{"key":"key-10.17116\/jnevro2024124091129-25","doi-asserted-by":"publisher","DOI":"10.1016\/0013-4694(91)90134-p"},{"key":"key-10.17116\/jnevro2024124091129-26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2017.12.018"},{"key":"key-10.17116\/jnevro2024124091129-27","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3366-04.2004"},{"key":"key-10.17116\/jnevro2024124091129-28","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2017.1304393"},{"key":"key-10.17116\/jnevro2024124091129-29","unstructured":"Kapitsa IG, Kokshenev II, Nerobkova LN, et al. The effect of himantan on the bioelectric activity of the brain of mice with MPTP \u2014 induced Parkinsonian syndrome. Eksperimental\u2019naya i klinicheskaya farmakologiya. 2013;4:3-6. (In Russ.)"},{"key":"key-10.17116\/jnevro2024124091129-30","unstructured":"Kapitsa IG, Nerobkova LN, Voronina TA. EEG correlates of an early stage of a Parkinson illness in experiment on mice of the strain C57BL\/6. Biomeditsina. 2014;1(1):54-60. (In Russ.)"}],"container-title":["S.S. Korsakov Journal of Neurology and Psychiatry"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T05:03:48Z","timestamp":1745384628000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova\/2024\/9\/1199772982024091129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,10,22]]}},"alternative-id":["10.17116\/jnevro2024124091129"],"URL":"https:\/\/doi.org\/10.17116\/jnevro2024124091129","relation":{},"ISSN":["1997-7298"],"issn-type":[{"type":"print","value":"1997-7298"}],"subject":[],"published":{"date-parts":[[2024,4,23]]}}}